NorthWest Biotherapeutics Inc (NWBO)

[photonic5]

We are still blinded. That means that the company doesn’t have insight into the results of the endpoints. That is the definition of “blinded”. Meeting endpoints or not is all speculation until the data is unblinded to the company.

The only thing we do know is how many total patients are still participating in the trial, how many are alive, and their demographics. That’s called blended data. We don’t know who got DCVax and who didn’t.

But common sense would dictate that there’s a reason for promising survival data in this group of patients. What could it be?